|
1
|
Schreiber G and McCrory DC: Performance
characteristics of different modalities for diagnosis of suspected
lung cancer: Summary of published evidence. Chest. 123 (Suppl
1):115S–128S. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Markou A, Sourvinou I, Vorkas PA, Yousef
GM and Lianidou E: Clinical evaluation of microRNA expression
profiling in non small cell lung cancer. Lung Cancer. 81:388–396.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Solomides CC, Evans BJ, Navenot JM,
Vadigepalli R, Peiper SC and Wang ZX: MicroRNA profiling in lung
cancer reveals new molecular markers for diagnosis. Acta Cytol.
56:645–654. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Landi MT, Zhao Y, Rotunno M, Koshiol J,
Liu H, Bergen AW, Rubagotti M, Goldstein AM, Linnoila I, Marincola
FM, et al: MicroRNA expression differentiates histology and
predicts survival of lung cancer. Clin Cancer Res. 16:430–441.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Petriella D, De Summa S, Lacalamita R,
Galetta D, Catino A, Logroscino AF, Palumbo O, Carella M, Zito FA,
Simone G, et al: miRNA profiling in serum and tissue samples to
assess noninvasive biomarkers for NSCLC clinical outcome. Tumour
Biol. 37:5503–5513. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Heller G, Altenberger C, Steiner I,
Topakian T, Ziegler B, Tomasich E, Lang G, End-Pfützenreuter A,
Zehetmayer S, Döme B, et al: DNA methylation of microRNA-coding
genes in non-small-cell lung cancer patients. J Pathol.
245:387–398. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
van Rooij E: The art of microRNA research.
Circ Res. 108:219–234. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pedersen AK, Mendes Lopes de Melo J, Mørup
N, Tritsaris K and Pedersen SF: Tumor microenvironment conditions
alter Akt and Na+/H+ exchanger NHE1
expression in endothelial cells more than hypoxia alone:
Implications for endothelial cell function in cancer. BMC Cancer.
17:5422017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Petrova V, Annicchiarico-Petruzzelli M,
Melino G and Amelio I: The hypoxic tumour microenvironment.
Oncogenesis. 7:102018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lanikova L, Reading NS, Hu H, Tashi T,
Burjanivova T, Shestakova A, Siwakoti B, Thakur BK, Pun CB, Sapkota
A, et al: Evolutionary selected Tibetan variants of HIF pathway and
risk of lung cancer. Oncotarget. 8:11739–11747. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mirsadraee S, Oswal D, Alizadeh Y, Caulo A
and van Beek E Jr: The 7th lung cancer TNM classification and
staging system: Review of the changes and implications. World J
Radiol. 4:128–134. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Irizarry RA, Hobbs B, Collin F,
Beazer-Barclay YD, Antonellis KJ, Scherf U and Speed TP:
Exploration, normalization, and summaries of high density
oligonucleotide array probe level data. Biostatistics. 4:249–264.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dweep H and Gretz N: miRWalk2.0: A
comprehensive atlas of microRNA-target interactions. Nat Methods.
12:6972015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The Gene
Ontology Consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kanehisa M and Goto S: KEGG: kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lin PY, Yu SL and Yang PC: MicroRNA in
lung cancer. Br J Cancer. 103:1144–1148. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Q, Wang S, Wang H, Li P and Ma Z:
MicroRNAs: Novel biomarkers for lung cancer diagnosis, prediction
and treatment. Exp Biol Med (Maywood). 237:227–235. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vannini I, Fanini F and Fabbri M:
MicroRNAs as lung cancer biomarkers and key players in lung
carcinogenesis. Clin Biochem. 46:918–925. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rosenfeld N, Aharonov R, Meiri E,
Rosenwald S, Spector Y, Zepeniuk M, Benjamin H, Shabes N, Tabak S,
Levy A, et al: MicroRNAs accurately identify cancer tissue origin.
Nat Biotechnol. 26:462–469. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yanaihara N, Caplen N, Bowman E, Seike M,
Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, et
al: Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Boutros PC, Lau SK, Pintilie M, Liu N,
Shepherd FA, Der SD, Tsao MS, Penn LZ and Jurisica I: Prognostic
gene signatures for non-small-cell lung cancer. Proc Natl Acad Sci
USA. 106:2824–2828. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hou J, Aerts J, den Hamer B, van Ijcken W,
den Bakker M, Riegman P, van der Leest C, van der Spek P, Foekens
JA, Hoogsteden HC, et al: Gene expression-based classification of
non-small cell lung carcinomas and survival prediction. PLoS One.
5:e103122010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu N, Zhang Q, Liu Q, Yang J and Zhang S:
A meta-analysis: microRNAs' prognostic function in patients with
nonsmall cell lung cancer. Cancer Med. 6:2098–2105. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Botling J, Edlund K, Lohr M, Hellwig B,
Holmberg L, Lambe M, Berglund A, Ekman S, Bergqvist M, Pontén F, et
al: Biomarker discovery in non-small cell lung cancer: Integrating
gene expression profiling, meta-analysis, and tissue microarray
validation. Clin Cancer Res. 19:194–204. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sun C, Sang M, Li S, Sun X, Yang C, Xi Y,
Wang L, Zhang F, Bi Y, Fu Y, et al: Hsa-miR-139-5p inhibits
proliferation and causes apoptosis associated with downregulation
of c-Met. Oncotarget. 6:39756–39792. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Watanabe K, Amano Y, Ishikawa R, Sunohara
M, Kage H, Ichinose J, Sano A, Nakajima J, Fukayama M, Yatomi Y, et
al: Histone methylation-mediated silencing of miR-139 enhances
invasion of non-small-cell lung cancer. Cancer Med. 4:1573–1582.
2015. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xu W, Hang M, Yuan CY, Wu FL, Chen SB and
Xue K: MicroRNA-139-5p inhibits cell proliferation and invasion by
targeting insulin-like growth factor 1 receptor in human non-small
cell lung cancer. Int J Clin Exp Pathol. 8:3864–3870.
2015.PubMed/NCBI
|
|
30
|
Dahlmans D, Houzelle A, Andreux P,
Jörgensen JA, Wang X, de Windt LJ, Schrauwen P, Auwerx J and Hoeks
J: An unbiased silencing screen in muscle cells identifies
miR-320a, miR-150, miR-196b, and miR-34c as regulators of skeletal
muscle mitochondrial metabolism. Mol Metab. 6:1429–1442. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Scrutinio D, Conserva F, Passantino A,
Iacoviello M, Lagioia R and Gesualdo L: Circulating microRNA-150-5p
as a novel biomarker for advanced heart failure: A genome-wide
prospective study. J Heart Lung Transplant. 36:616–624. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Palagani A, Op de Beeck K, Naulaerts S,
Diddens J, Sekhar Chirumamilla C, Van Camp G, Laukens K, Heyninck
K, Gerlo S, Mestdagh P, et al: Ectopic microRNA-150-5p
transcription sensitizes glucocorticoid therapy response in MM1S
multiple myeloma cells but fails to overcome hormone therapy
resistance in MM1R cells. PLoS One. 9:e1138422014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Filipska M, Skrzypski M, Czetyrbok K,
Stokowy T, Stasiłojć G, Supernat A, Jassem J, Żaczek AJ and Bigda
J: miR-192 and miR-662 enhance chemoresistance and invasiveness of
squamous cell lung carcinoma. Lung Cancer. 118:111–118. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Świtlik W, Karbownik MS, Suwalski M, Kozak
J and Szemraj J: miR-30a-5p together with miR-210-3p as a promising
biomarker for non-small cell lung cancer: A preliminary study.
Cancer Biomark. 21:479–488. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Narita M, Shimura E, Nagasawa A, Aiuchi T,
Suda Y, Hamada Y, Ikegami D, Iwasawa C, Arakawa K, Igarashi K, et
al: Chronic treatment of non-small-cell lung cancer cells with
gefitinib leads to an epigenetic loss of epithelial properties
associated with reductions in microRNA-155 and −200c. PLoS One.
12:e01721152017. View Article : Google Scholar : PubMed/NCBI
|
